BERKSHIRE HATHAWAY INC (BRK-B) vs JOHNSON & JOHNSON(JNJ)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | BRK-B | JNJ |
|---|---|---|
| Sector | Financials | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $371.44B | $94.19B |
| Revenue growth (YoY) | ▲ 0.0% | ▲ 6.0% |
| Net income | $67.26B | $26.80B |
| Gross margin | — | 67.9% |
| Diluted EPS | — | $11.03 |
| Insider net (6 mo) | −787.6K sh · 4 sells · 2 buys | −40.8K sh · 6 sells · 0 buys |
| Institutional owners | 50 | 47 |
| Institutional value held | $215.24B | $294.77B |
| Next earnings (est.) | Around Nov 2, 2026 | Around Oct 13, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About BERKSHIRE HATHAWAY INC (BRK-B)
Berkshire Hathaway Inc., a Delaware-domiciled holding company headquartered in Omaha, Nebraska, operates a diverse portfolio of businesses managed under a highly decentralized structure, with its Chief Executive Officer responsible for major capital allocation
About JOHNSON & JOHNSON (JNJ)
Johnson & Johnson, incorporated in New Jersey in 1887, is a global healthcare holding company with approximately 138,200 full-time-equivalent employees engaged in the research, development, manufacture, and sale of a broad range of healthcare products.
Source: SEC EDGAR.